BSc (Physiotherapy), MPH, Acting Senior Epidemiologist, NSW Ministry of Health, NSW.
MBBS, MA (Oxon), MSc (LSHTM), Medical Director, Family Planning NSW, Ashfield, NSW; Clinical Associate Professor, Discipline of Obstetrics, Gynaecology and Neonatology, Faculty of Medicine and Health, University of Sydney, NSW.
Aust J Gen Pract. 2021 Aug;50(8):573-579. doi: 10.31128/AJGP-08-20-5570.
The 'Heavy menstrual bleeding (HMB) clinical care standard' was released in October 2017. The aim of this study was to determine the rate and management of HMB by Australian general practitioners (GPs) prior to release of the Standard.
Data collected between April 2000 to March 2016 (inclusive) in the Bettering the Evaluation and Care of Health program were analysed for HMB management.
The rate at which GPs managed HMB increased over the study period. The combined oral contraceptive pill was the most frequently prescribed treatment, except among women aged 45-54 years. There were low prescribing/insertion rates of the levonorgestrel intrauterine system (LNG-IUS) for women aged 25-54 years, and none for patients aged 12-24 years.
Improved understanding of patient and GP perspectives, and further education and training, could increase use of the LNG-IUS and other pharmaceutical treatments where appropriate, as recommended by the HMB clinical care standard.
《重度月经过多（HMB）临床护理标准》于 2017 年 10 月发布。本研究旨在确定该标准发布前澳大利亚全科医生（GP）对 HMB 的处理率和处理方法。
对 Bettering the Evaluation and Care of Health 项目在 2000 年 4 月至 2016 年 3 月期间（包括在内）收集的数据进行了分析，以了解 HMB 的管理情况。
在研究期间，GP 管理 HMB 的比例有所增加。除了 45-54 岁的女性外，联合口服避孕药是最常开的治疗药物。25-54 岁女性的左炔诺孕酮宫内节育系统（LNG-IUS）的开处/插入率较低，12-24 岁患者则无。
如 HMB 临床护理标准所建议，进一步了解患者和 GP 的观点，并进行更多的教育和培训，可以增加 LNG-IUS 和其他适当药物治疗的使用。
